ZENEX Trademark

Trademark Overview


On Thursday, November 20, 2025, a trademark application was filed for ZENEX with the United States Patent and Trademark Office. The USPTO has given the ZENEX trademark a serial number of 99507709. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Thursday, April 2, 2026. This trademark is owned by St. Jude Medical, LLC. The ZENEX trademark is filed in the Medical Instrument Products category with the following description:

Implantable cardiac pulse generators and implantable cardioverter defibrillators.
zenex

General Information


Serial Number99507709
Word MarkZENEX
Filing DateThursday, November 20, 2025
Status641 - NON-FINAL ACTION - MAILED
Status DateThursday, April 2, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesImplantable cardiac pulse generators and implantable cardioverter defibrillators.

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, November 20, 2025
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSt. Jude Medical, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressSt. Paul, MN 55117
US

Trademark Events


Event DateEvent Description
Thursday, November 20, 2025NEW APPLICATION ENTERED
Thursday, November 20, 2025APPLICATION FILING RECEIPT MAILED
Monday, November 24, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 26, 2026ASSIGNED TO EXAMINER
Thursday, April 2, 2026NON-FINAL ACTION WRITTEN
Thursday, April 2, 2026NON-FINAL ACTION E-MAILED
Thursday, April 2, 2026NOTIFICATION OF NON-FINAL ACTION E-MAILED